Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Shares Issued (2016 - 2025)

Amphastar Pharmaceuticals (AMPH) has 12 years of Shares Issued data on record, last reported at $2.0 million in Q4 2025.

  • For Q4 2025, Shares Issued changed N/A year-over-year to $2.0 million; the TTM value through Dec 2025 reached $8.0 million, changed N/A, while the annual FY2025 figure was $2.9 million, N/A changed from the prior year.
  • Shares Issued reached $2.0 million in Q4 2025 per AMPH's latest filing, up from $379000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $5.7 million in Q4 2021 and bottomed at $379000.0 in Q3 2025.
  • Average Shares Issued over 4 years is $2.6 million, with a median of $2.1 million recorded in 2022.
  • Peak YoY movement for Shares Issued: skyrocketed 205.5% in 2021, then tumbled 64.0% in 2022.
  • A 4-year view of Shares Issued shows it stood at $5.7 million in 2021, then crashed by 64.0% to $2.0 million in 2022, then surged by 74.68% to $3.6 million in 2023, then tumbled by 44.33% to $2.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Issued were $2.0 million in Q4 2025, $379000.0 in Q3 2025, and $3.6 million in Q4 2023.